Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Regorafenib for the treatment of hepatocellular carcinoma.
Tovoli F, Granito A, De Lorenzo S, Bolondi L. Tovoli F, et al. Among authors: de lorenzo s. Drugs Today (Barc). 2018 Jan;54(1):5-13. doi: 10.1358/dot.2018.54.1.2736667. Drugs Today (Barc). 2018. PMID: 29569657 Review.
Cholangiocarcinoma: from risk to prevention?
Brandi G, De Lorenzo S, Tovoli F. Brandi G, et al. Among authors: de lorenzo s. Transl Gastroenterol Hepatol. 2016 Jun 24;1:53. doi: 10.21037/tgh.2016.06.02. eCollection 2016. Transl Gastroenterol Hepatol. 2016. PMID: 28138620 Free PMC article. No abstract available.
Microbiota, NASH, HCC and the potential role of probiotics.
Brandi G, De Lorenzo S, Candela M, Pantaleo MA, Bellentani S, Tovoli F, Saccoccio G, Biasco G. Brandi G, et al. Among authors: de lorenzo s. Carcinogenesis. 2017 Mar 1;38(3):231-240. doi: 10.1093/carcin/bgx007. Carcinogenesis. 2017. PMID: 28426878 Review.
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation.
Ravaioli M, Cucchetti A, Pinna AD, De Pace V, Neri F, Barbera MA, Maroni L, Frega G, Palloni A, De Lorenzo S, Ripoli MC, Pantaleo MA, Cescon M, Del Gaudio M, Brandi G. Ravaioli M, et al. Among authors: de lorenzo s, de pace v. Sci Rep. 2017 Sep 12;7(1):11305. doi: 10.1038/s41598-017-11810-z. Sci Rep. 2017. PMID: 28900245 Free PMC article.
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation.
Trevisani F, Brandi G, Garuti F, Barbera MA, Tortora R, Casadei Gardini A, Granito A, Tovoli F, De Lorenzo S, Inghilesi AL, Foschi FG, Bernardi M, Marra F, Sacco R, Di Costanzo GG. Trevisani F, et al. Among authors: de lorenzo s. J Cancer Res Clin Oncol. 2018 Feb;144(2):403-414. doi: 10.1007/s00432-017-2556-6. Epub 2017 Dec 16. J Cancer Res Clin Oncol. 2018. PMID: 29249005 Free article.
118 results